Epstein Secrets

ward to seeing you again, either in Cambridge or in NYC, which I'll probably get to in the next couple of weeks. Best wishes, Don Donald B. Rubin John L. Loeb Professor of Statistics Department of Statistics, Harvard University Cambridge MA 02138 ru bin stat.harvard.edu EFTA00636422 On Dec 2, 2016, a

r you around on the weekend in cambridge.? On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin < wrote: OK. I'll get back to you after I make contact with Adriaan again, and my plans settle a bit. On Dec 7, 2016, at 10:38 AM, jeffrey E. <jeevacation®gmail.com> wrote: three way skype for 3. and yes 1 face to f

effects is the following. This morning I just had an exchange of emails with the CEO of EB, whom I've known and worked with for about three years, Adriaan Tuiten. He wrote that FDA has agreed with EB's proposal for more trials, and the EB board of directors just approved the issuance of about 12 million Euros

idg= or in NYC, which I'll probably get to in the next couple of weeks= Best wishes, Do= 2 EFTA_R1_01918721 EFTA02667102 =br> Donald B. Rubin John L. Loeb Professor of Statistics Department of Statistics, Harvard University On Dec 2, 2016, at 9:41 AM, jeffrey E. <[email protected] <mailto:jeevaca

around =n the weekend in cambridge.? =br> On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin= wrote: OK. I'll get back to you=after I make contact with Adriaan again, and my plans settle a bit. <=iv> On Dec=7, 2016, at 10:38 AM, jeffrey E. <[email protected] <mailto:[email protected]=m> wrote: =div

effects is the following. This morni=g I just had an exchange of emails with the CEO of EB, whom I've k=own and worked with for about three years, Adriaan Tuiten. He wrote =hat FDA has agreed with EB's proposal for more trials, and the EB =oard of directors just approved the issuance of about 12 million Euros

or in NYC, which I'll probably get to in the next couple of wee=s. Best wishes, Don cr. class="m_-1196805788815373682gmail_msg"> Donald B. Rubi= John L. Loeb Professor of St=tistics Department of Statist=cs, Harvard University 1 Oxfo=d Street Cambridge MA 02138I > On Dec 2, 2016, at 9:41 AM, jeffrey E.

topic of placebo respon=e, which are still not that wonderfully written. =. If interested in exploring investing in EB, I can put you in touch=with Adriaan, who lives in Amsterdam. Are any of =hese appealing? I prefer 1 to 2. I think a face to face versio= of 3 could be arranged either here or there. l

o effects is the following. This morning I just had an =xchange of emails with the CEO of EB, whom I've known and worked w=th for about three years, Adriaan Tuiten. He wrote that FDA has agre=d with EB's proposal for more trials, and the EB board of director= just approved the issuance of about 12 million Euro

ward to =eeing you again, either in Cambridge or in NYC, which I'll =robably get to in the next couple of weeks. Best wishes, Don Donald B. Rubin John L. Loeb Professor of Statistics Department =f Statistics, Harvard University 1 Oxford Street Cambridge MA 02138 On Dec 2, 2016, at 9:41 AM, jeffrey E. <j

cts is the following. =nbsp;This morning I just had an exchange of emails with the CEO of EB, =hom I've known and worked with for about three years, Adriaan =uiten. He wrote that FDA has agreed with EB's proposal =or more trials, and the EB board of directors just approved the =ssuance of about 12 milli